benazepril hydrochloride; hydrochlorothiazide
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (benazepril hydrochloride; hydrochlorothiazide) by Viatris (2) is clinical pharmacology mechanism of action benazepril and benazeprilat inhibit angiotensin converting enzyme (ace) in human subjects and in animals. Approved for hypertension. First approved in 2004.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY Mechanism of Action Benazepril and benazeprilat inhibit angiotensin converting enzyme (ACE) in human subjects and in animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also…
Worked on BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.